Cost-effectiveness of Interferon-α2b Treatment for Hepatitis B e Antigen-Positive Chronic Hepatitis B

B. Wong, John; S. Koff, Raymond; Tine, Fabio; G. Pauker, Stephen

doi:10.7326/0003-4819-122-9-199505010-00004

Public

Cost-effectiveness of Interferon-α2b Treatment for Hepatitis B e Antigen-Positive Chronic Hepatitis B

Published in Annals of Internal Medicine • May 1, 1995

Authors:

John B. Wong

Raymond S. Koff

Fabio Tine

Abstract

OBJECTIVE: To estimate the cost-effectiveness of interferon-alpha 2B for the treatment of patients with chronic hepatitis B infection who are positive for hepatitis B e antigen (HBeAg). DESIGN: Meta-analysis of nine randomized controlled trials and cost-effectiveness analysis, projecting the clinica...

Subject

Medicine

HBeAg

Life expectancy

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!